These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 17913561)

  • 21. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease.
    Moro E; Lozano AM; Pollak P; Agid Y; Rehncrona S; Volkmann J; Kulisevsky J; Obeso JA; Albanese A; Hariz MI; Quinn NP; Speelman JD; Benabid AL; Fraix V; Mendes A; Welter ML; Houeto JL; Cornu P; Dormont D; Tornqvist AL; Ekberg R; Schnitzler A; Timmermann L; Wojtecki L; Gironell A; Rodriguez-Oroz MC; Guridi J; Bentivoglio AR; Contarino MF; Romito L; Scerrati M; Janssens M; Lang AE
    Mov Disord; 2010 Apr; 25(5):578-86. PubMed ID: 20213817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolite ratios in the posterior cingulate cortex do not track cognitive decline in Parkinson's disease in a clinical setting.
    Almuqbel M; Melzer TR; Myall DJ; MacAskill MR; Pitcher TL; Livingston L; Wood KL; Keenan RJ; Dalrymple-Alford JC; Anderson TJ
    Parkinsonism Relat Disord; 2016 Jan; 22():54-61. PubMed ID: 26627939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two-year follow-up on the effect of unilateral subthalamic deep brain stimulation in highly asymmetric Parkinson's disease.
    Kim HJ; Paek SH; Kim JY; Lee JY; Lim YH; Kim DG; Jeon BS
    Mov Disord; 2009 Feb; 24(3):329-35. PubMed ID: 19006187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medication dose reductions after pallidal versus subthalamic stimulation in patients with Parkinson's disease.
    Evidente VG; Premkumar AP; Adler CH; Caviness JN; Driver-Dunckley E; Lyons MK
    Acta Neurol Scand; 2011 Sep; 124(3):211-4. PubMed ID: 20969559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subthalamic stimulation modulates cortical control of urinary bladder in Parkinson's disease.
    Herzog J; Weiss PH; Assmus A; Wefer B; Seif C; Braun PM; Herzog H; Volkmann J; Deuschl G; Fink GR
    Brain; 2006 Dec; 129(Pt 12):3366-75. PubMed ID: 17077105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term outcomes of bilateral subthalamic nucleus stimulation in patients with advanced Parkinson's disease.
    Liang GS; Chou KL; Baltuch GH; Jaggi JL; Loveland-Jones C; Leng L; Maccarone H; Hurtig HI; Colcher A; Stern MB; Kleiner-Fisman G; Simuni T; Siderowf AD
    Stereotact Funct Neurosurg; 2006; 84(5-6):221-7. PubMed ID: 17063043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Magnetic resonance spectroscopy in Parkinson's disease and multiple system atrophy].
    Aotsuka A; Shinotoh H; Hattori T
    Nihon Rinsho; 1997 Jan; 55(1):249-54. PubMed ID: 9014459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic factors of subthalamic stimulation in Parkinson's disease: a comparative study between short- and long-term effects.
    Tsai ST; Lin SH; Chou YC; Pan YH; Hung HY; Li CW; Lin SZ; Chen SY
    Stereotact Funct Neurosurg; 2009; 87(4):241-8. PubMed ID: 19556833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic stimulation of the subthalamic nucleus increases daily on-time without dyskinesia in advanced Parkinson's disease.
    Portman AT; van Laar T; Staal MJ; Rutgers AW; Journee HL; Leenders KL
    Parkinsonism Relat Disord; 2006 Apr; 12(3):143-8. PubMed ID: 16460986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term effects of bilateral deep brain stimulation of the subthalamic nucleus on depression in patients with Parkinson's disease.
    Wang X; Chang C; Geng N; Li N; Wang J; Ma J; Xue W; Zhao W; Wu H; Wang P; Gao G
    Parkinsonism Relat Disord; 2009 Sep; 15(8):587-91. PubMed ID: 19403325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term outcome of young onset Parkinson's disease after subthalamic stimulation--a cross-sectional study.
    Tsai ST; Hung HY; Hsieh TC; Lin SH; Lin SZ; Chen SY
    Clin Neurol Neurosurg; 2013 Oct; 115(10):2082-7. PubMed ID: 23916724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolite profile in the basal ganglia of children with cerebral palsy: a proton magnetic resonance spectroscopy study.
    Kulak W; Sobaniec W; Smigielska-Kuzia J; Kubas B; Walecki J
    Dev Med Child Neurol; 2006 Apr; 48(4):285-9. PubMed ID: 16542516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Staged bilateral deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease.
    Tanei T; Kajita Y; Kaneoke Y; Takebayashi S; Nakatsubo D; Wakabayashi T
    Acta Neurochir (Wien); 2009 Jun; 151(6):589-94. PubMed ID: 19381434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subthalamic nucleus stimulation in Parkinson's disease: postoperative CT-MRI fusion images confirm accuracy of electrode placement using intraoperative multi-unit recording.
    Shin M; Lefaucheur JP; Penholate MF; Brugières P; Gurruchaga JM; Nguyen JP
    Neurophysiol Clin; 2007 Dec; 37(6):457-66. PubMed ID: 18083502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bilateral subthalamic deep brain stimulation after bilateral pallidal deep brain stimulation for Parkinson's disease.
    Deogaonkar M; Monsalve GA; Scott J; Ahmed A; Rezai A
    Stereotact Funct Neurosurg; 2011; 89(2):123-7. PubMed ID: 21336008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebral metabolic alterations in human immunodeficiency virus-related encephalopathy detected by proton magnetic resonance spectroscopy. Comparison between sequences using short and long echo times.
    Salvan AM; Vion-Dury J; Confort-Gouny S; Nicoli F; Lamoureux S; Cozzone PJ
    Invest Radiol; 1997 Aug; 32(8):485-95. PubMed ID: 9258737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of the effects of unilateral electrode dysfunction in patients with Parkinson disease undergoing bilateral subthalamic nucleus deep brain stimulation.
    Park YS; Kim JP; Chang WS; Lee PH; Sohn YH; Chang JW
    Neurosurgery; 2012 Mar; 70(1 Suppl Operative):163-9; discussion 169. PubMed ID: 21768919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unchanged basal ganglia N-acetylaspartate and glutamate in idiopathic Parkinson's disease measured by proton magnetic resonance spectroscopy.
    Clarke CE; Lowry M; Horsman A
    Mov Disord; 1997 May; 12(3):297-301. PubMed ID: 9159722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implantation of electrodes for deep brain stimulation of the subthalamic nucleus in advanced Parkinson's disease with the aid of intraoperative microrecording under general anesthesia.
    Hertel F; Züchner M; Weimar I; Gemmar P; Noll B; Bettag M; Decker C
    Neurosurgery; 2006 Nov; 59(5):E1138; discussion E1138. PubMed ID: 17143204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subthalamic nucleus stimulation does not cause deterioration of preexisting hallucinations in Parkinson's disease patients.
    Yoshida F; Miyagi Y; Kishimoto J; Morioka T; Murakami N; Hashiguchi K; Samura K; Sakae N; Yamasaki R; Kawaguchi M; Sasaki T
    Stereotact Funct Neurosurg; 2009; 87(1):45-9. PubMed ID: 19174620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.